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perform than cystgastrostomy but had a slightly lower rate of postoperative
complications including bleeding4; the cyst recurrence rate was virtually identical (8
per cent versus 10 per cent). The same tendency towards a higher complication rate
after cystgastrostomy emerges from three previous reports6-8.
In summary, cystgastrostomy is an appropriate procedure for ’mature’ acute
pseudocysts that are large enough to cause symptoms but not so large as to prevent
adequate drainage by this approach. For the rest (probably the majority), cystjeju-
nostomy offers a safer alternative at the expense of a longer operation.
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EFFECT OF INTRAOPERATIVE HYPOTENSION ON
SURVIVAL AFTER RESECTION OF COLORECTAL
LIVER METASTASES
ABSTRACT
Younes, R.N., Rogatko, A. and Brennan, M.F. (1991) The influence of intraopera-
tive hypotension and perioperative blood transfusion on disease-free survival in
patients with complete resection of colorectal liver metastases. Annals of Surgery,
214, 107-113.132 HPB INTERNATIONAL
An increased interest in surgical treatment of liver metastases from colorectal origin
has evolved recently. However not all patients benefit from this approach, with early
recurrence and death still being encountered. To evaluate clinical as well as
perioperative factors that might significantly affect the outcome of patients with
completely resected colorectal liver metastases, we examined 116 patients who
underwent resection between September 1987 and August 1989. Median follow-up
time was 13.2 months (0.6 to 31.4 months). The overall survival rate was 91% at 1
year and 75% at 2 years. Median survival was not reached. Median disease-free
survival time was 11.5 months, with 49.4% and 21.2% of the patients being free of
disease at 1 and 2 years, respectively. By univariate analysis, site of primary
colorectai cancer, preoperative carcinoembryonic antigen (CEA) level, size of
metastases, number of metastases, length of operation time, percentage mean
arterial pressure, number of hypotensive episodes, duration of hypotensive episodes,
and whole blood transfusion significantly affected recurrence rate following resec-
tion. However only site of primary tumor, CEA, number of metastases, and number
of hypotensive episodes remained significant in the multivariate analysis. The most
significant single factor that affected recurrence rate was the number of hypotensive
episodes during the operative procedure. It is concluded that hypotensive episodes,
even when well controlled, should be avoided during operation to maximize the
chances of cure and prolong disease-free survival of patients with colorectal liver
metastases.
PAPER DISCUSSION
KEY WORDS" Liver resection, liver metastases, intraoperative hypotension
The aim of this paper was to evaluate pre- and perioperative factors that could
affect disease recurrence and survival in patients undergoing complete hepatic
resection for colorectal liver metastases. The factors which significantly affected the
recurrence rate following resections in multivariate analysis were the site of the
primary tumor, the CEA level before resection, the number of metastases and the
number of hypotensive episodes during surgery.
The authors conclude that hypotensive episodes should be avo;,ded during the
resections of liver metastases in order to improve the chances for cure. This
message is original.
This study reports an homogeneous series of more than one hundred patients
originating from one institution and operated upon during a short period of time (2
years). However the duration of follow-up was short, ranging from 0.6 to 31.4
months (median 13.2). This can jeopardize the conclusions since it is well known
that many recurrences after resection of colorectal liver metastases occur after the
first year of follow-up and are not taken into account in this series. In the
multicenter study of Hughes recurrences were observed in 70% of 607 patients
who had undergone curative resections, but only half of these recurrences (36% of
total patients) were observed during the first year of follow-up. Thus the conclu-
sions of the present paper should relate only to early recurrences.
Preoperative CEA level is a well recognized prognostic factor. However it is
more surprising that the grade of the primary cancer did not affect survival and on
the other hand that the site of the primary cancer was a statistically significantHPB INTERNATIONAL 133
factor in multivariate analysis. This is contrary to other recent large studies23 and
may be related to the relatively small number of patients included in the study and
to the short follow-up.
The major interest of this paper is related to its results concerning the role of
perioperative factors. The most significant factor that affected recurrence rate was
the number of hypotensive episodes during the operative procedure and one of the
conclusions was that hypotensive episodes should be avoided to minimize the risk
of recurrences. This conclusion raises several comments. Baseline MAP was
defined as the pressure when the surgeon started the operation but this period is
frequently associated with important variations in the arterial pressure. Conversely
hypotension was defined as a decrease of 20% of baseline MAP. For a baseline
value of 140 mm Hg, 112 mm Hg was considered as an hypotensive episode in the
same patient.
During liver resection many events may result in arterial hypotension bleeding,
mobilisation of the liver, compression of the inferior vena cava and also the Pringle
Manoeuvre itself or complete vascular exclusion of the liver. It would have been
interesting to know if such procedures were used. In Table 3 the number of
hypotensive episodes appears to be related to the time of operation, to the blood
loss and to the duration of hypotensive episodes. Clearly all these factors are
encountered in a difficult surgical procedure; more details concerning the surgical
technique used would have been useful to interprete these data. Moreover
concerning transfusion, whole blood transfusion was the single factor that signifi-
cantly affected recurrence in univariate analysis. Usually such blood transfusions
are administered in patients who actively bleed. This factor can also be considered
as a reflection of the technical difficulty of liver resection.
Blood transfusion is known to affect post operative mortality in major liver
surgery. It has also been suggested that it could affect the recurrence rate due to a
potential immunosuppresive effect4. There is little information on the effect of
intraoperative hemodynamic changes on the immune system.
The conclusion that perioperative bleeding and intraoperative hypotension
should be avoided makes good sense, However the same criteria should be
analysed in other large series with a sufficient follow-up before the prognostic value
of these factors is taken for granted.
B. Nordlinger., P. Balladur., E. Delva**
Department of Surgery. and
Anesthesiology**
H6pital Saint-Antoine
184 Faubourg Saint-Antoine
75012 Paris, France
REFERENCES
1. Doci, R., German, L., Bigmani, P., Montallo, F., Moranito, A. and Bozzetti, F. (1991) One
hundred patients with hepatic metastases from colorectal cancer treated by resection analysis of
prognostic determinant Br. J. Surg., 78, 797-801
2. Hughes, K.S., Simon, R., Songhorabodi, S. et al. (1986) Resection of the liver for colorectal
carcinoma metastase. A multi institutional study of patterns of recurrence. Surgery, 1t, 268-274134 HPB INTERNATIONAL
3. Scheele, J., Stangl, R., Altendorf-Hofman, A., Gall, F.P. et al. (1991) Indications of prognosis after
hepatic resection for colorectal secondaries. Surgery, 110, 13-23
4. Schriemer, P.A., Longnecker, D. and Mintz, P.D. (1989) The possible immunosuppression effects
of perioperative blood transfusion in cancer patients. Anesthesiology, 65, 422-428
SHOULD NEITHER SCLEROTHERAPY NOR
PROPRANOLOL BE USED PROPHYLACTICALLY
FOR OESOPHAGEAL VARICES?
ABSTRACT
The PROVA Study Group. (1991) Prophylaxis offirst hemorrhagefrom esophageal
oarices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized
multicenter trial. Hepatology; 14, 1016-1024
The objective of this randomized multicenter trial was to assess the prophylactic
effect on the incidence and severity of the first variceal hemorrhage of endoscopic
sclerotherapy, propranolol and the combination of the two compared with none of
these treatments in patients with cirrhosis and esophageal varices. Among 819
cirrhotic patients who never had experienced variceal bleeding, esophagoscopy
revealed varices in 379, ofwhom 286 were enrolled in the trial; 73 were allocated to
sclerotherapy (paravenous polidocanoi [10 mg/mi] every 1 to 2 wk until eradication),
68 to propranolol (slow-release preparation in one daily dose adjusted to provide
about 25% heart rate reduction), 73 to both treatments and 72 to neither of the two
treatments. The patients were observed for up to 42 months, with an ,average of 15
months. After variceal bleeding, patients in all groups received sclerotherapy only.
The incidences of variceal bleeding (n 50) were almost identical in the four
groups. The relative risk (with 95% confidence limits) with sclerotherapy was 1.06
(0.61 to 1.84), and the relative risk with propranolol was 0.92 (0.53 to 1.60). The
mortality rate after variceal bleeding (n 29) did not differ significantly either. The
mortality rate without variceal bleeding (n 46) was 2.75 (1.45 to 5.22) times
higher in the sclerotherapy groups than in the nonsclerotherapy groups (p 0.002),
whereas propranolol showed no effect, the relative risk being 1.17 (0.66 to 2.10). The
total mortality rate showed no significant difference between the sclerotherapy,
propranolol and control groups, but the combined therapy group had a significantly
increased mortality rate.
This trial yielded evidence against prophylaxis of variceal hemorrhage in cirrhosis
by endoscopic sclerosing injections, with or without propranolol and no support of
propranolol used alone. (Hepatology 1991; 14:000-000.)